Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

CRF1 receptor antagonist may be beneficial in stress-induced psychosomatic disorders

June 24, 1999

Potential new use for donepezil: Rx of dyskinesias and other symptoms in IPD

June 24, 1999

Copley launches first controlled drug

June 24, 1999

Ovine colostrum-derived polypeptide may represent novel treatment strategy in AD

June 23, 1999

UCB's levetiracetam superior to placebo in refractory partial seizures

June 23, 1999

New study provides evidence supporting efficacy of cladribine in MS

June 23, 1999

Water-soluble and orally bioavailable salt of known sigma ligand prepared at Lundbeck

June 23, 1999

Tramadol recommended as a safe and effective treatment for restless legs syndrome

June 23, 1999

Results from first phase II trial of orally active PAF inhibitor in multiple sclerosis discouraging

June 22, 1999

Ziconotide use not associated with respiratory depression according to rat study

June 22, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.